Antiproteinuric therapy and Fabry nephropathy: Factors associated with preserved kidney function during agalsidase-beta therapy
David G. Warnock*, Christie P. Thomas, Bojan Vujkovac, Ruth C. Campbell, Joel Charrow, Dawn A. Laney, Leslie L. Jackson, William R. Wilcox, Christoph Wanner
Dive into the research topics of 'Antiproteinuric therapy and Fabry nephropathy: Factors associated with preserved kidney function during agalsidase-beta therapy'. Together they form a unique fingerprint.